Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-242-7 | CAS number: 104-83-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1986-10-27 to 1986-12-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- : Number of animals
- Principles of method if other than guideline:
- Number of tested animals: 10
Number of animals in control group: 5 - GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Non-LLNA method results available from pre-LLNA time
Test material
- Reference substance name:
- α,4-dichlorotoluene
- EC Number:
- 203-242-7
- EC Name:
- α,4-dichlorotoluene
- Cas Number:
- 104-83-6
- Molecular formula:
- C7H6Cl2
- IUPAC Name:
- 1-chloro-4-(chloromethyl)benzene
- Details on test material:
- p-Chlorobenzyl chloride D
State of matter: solid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Pirbright -White
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Guinea pig, strain: Pirbright-White
- Source: Hoechst AG, Kastengrund, SPF-Zucht
- Weight at study initiation: 317 g
- 15 ( female)
ENVIRONMENTAL CONDITIONS
- Diet: ERKA-Mischfutter Nr. 8300 für Meerschweinchen und Kaninchen (ad libitum)
- Water: tap water (ad libitum)
- Temperature: 22 °C +/- 3 °C
- Humidity: 50 % +/- 20 %
- Photoperiod (hrs dark / hrs light): 12 / 12
- Acclimation: > 5 days
- Housing: 4 animal per cage
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: induction: paraffin oil; challenge: vaseline
- Concentration / amount:
- 1 % test substance for intradermal and epicutaneous treatment
Challenge
- Concentration / amount:
- 1 % test substance for intradermal and epicutaneous treatment
- No. of animals per dose:
- 10 (dose group)
5 (control groups and satellite group) - Details on study design:
- RANGE FINDING TESTS:
Estimation of the concentration for epicutaneous induction and challenge treatment:
Epicutaneous application of p-chlorobenzyl chloride at concentrations of 10%, 1%, and 0.1% in vaseline (6 animals).
Dermal treatment with 10 % test item caused barley perceptible erythema and slight edema. 1 % and 0.1 % did not cause any skin reactions.
Estimation of the concentration for intradermal induction exposure:
Injection of p-chlorobenzyl chloride at concentrations of 5%, 1%, and 0.2% in paraffin oil (3 animals).
Intradermal injection of 0.2 % test item caused slight erythema and edema. 1 % and 5 % caused more severe erythema and edema. 5 % caused also hardening of the skin.
Satellite group:
Dermal treatment with 1 % test item of the animals pre-treated with Freud's adjuvans did not result in skin reactions.
Based on these results, 1 % was selected as concentration for intradermal and dermal treatemtent.
MAIN STUDY
A1. INDUCTION EXPOSURE (intradermal)
- Test group: Position 1: 2 x 0.1 mL 50 % Freunds Complete Adjuvant (FCA); Position 2: 2 x 0.1 mL 1 % in paraffin oil; Position 3: 2 x 0.1 mL 1 % in FCA
- Control group: Position 1: 2 x 0.1 mL 50 % Freunds Complete Adjuvant (FCA); Position 2: 2 x 0.1 mL paraffin oil; Position 3: 2 x 0.1 mL 50 % FCA
- Satellite group: Position 1: 2 x 0.1 mL 50 % Freunds Complete Adjuvant (FCA); Position 2: 2 x 0.1 mL paraffin oil; Position 3: 2 x 0.1 mL 50 % FCA
- Site: upper ridge (near shoulder region)
- Frequency of applications: 1
- Concentrations: 1%
A2. INDUCTION EXPOSURE (dermal)
- No. of exposures: 1
- Exposure period: 48 h
- Test group: 1% in vaseline
- Control group: vaseline
- Satellite group: vaseline
- Site: intradermal exposure sites
- Concentrations: 1%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day of challenge: 22 (test group/control group), 15 (satellite group)
- Exposure period: 24 h
- Test group: 1% in vaseline
- Control group: 1% in vaseline
- Satellite group: 1% in vaseline
- Site: left flank
- Concentrations: 1%
- Evaluation (hr after challenge): 48 h, 72 h - Challenge controls:
- see above
Results and discussion
- Positive control results:
- not applicable
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1.0 % p-Chlorobenzyl chloride
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Erythema: score 3 (mean); oedema: score 1.8 (mean, 6/10); scab: 8/10 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1.0 % p-Chlorobenzyl chloride. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Erythema: score 3 (mean); oedema: score 1.8 (mean, 6/10); scab: 8/10 animals.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 1.0 % p-Chlorobenzyl chloride
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Erythema: score 3.1 (mean); oedema: score 2 (mean, 3/10); scab: 7/10 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 1.0 % p-Chlorobenzyl chloride. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Erythema: score 3.1 (mean); oedema: score 2 (mean, 3/10); scab: 7/10 animals.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1.0 % p-Chlorobenzyl chloride
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Erythema and oedema: Score 0 (mean)
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1.0 % p-Chlorobenzyl chloride. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: Erythema and oedema: Score 0 (mean).
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 1.0 % p-Chlorobenzyl chloride
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Erythema and oedema: Score 0 (mean)
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 1.0 % p-Chlorobenzyl chloride. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: Erythema and oedema: Score 0 (mean).
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- other: satellite
- Dose level:
- 1.0 % p-Chlorobenzyl chloride
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Erythema and oedema: Score 0 (mean)
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: other: satellite. Dose level: 1.0 % p-Chlorobenzyl chloride. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: Erythema and oedema: Score 0 (mean).
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- other: satellite
- Dose level:
- 1.0 % p-Chlorobenzyl chloride
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Erythema and oedema: Score 0 (mean)
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: other: satellite. Dose level: 1.0 % p-Chlorobenzyl chloride. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: Erythema and oedema: Score 0 (mean).
- Reading:
- 1st reading
- Group:
- positive control
- Remarks on result:
- other: no positive control group
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Executive summary:
In a guinea pig maximisation test p-chlorobenzyl chloride was tested at a challenge concentration of 1% in vaseline. The animals were induced with 1 % test item in paraffin oil and vaseline for intradermal and dermal induction, respectively. No signs of systemic toxicity were observed in the dose group during the study. All test group animals showed signs of sensitisation following challenge treatment. In the control group and satellite group, no local effects were registered after the challenge. In this study it was demonstrated that p-chlorobenzyl chloride is a dermal sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.